ZA853823B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA853823B
ZA853823B ZA853823A ZA853823A ZA853823B ZA 853823 B ZA853823 B ZA 853823B ZA 853823 A ZA853823 A ZA 853823A ZA 853823 A ZA853823 A ZA 853823A ZA 853823 B ZA853823 B ZA 853823B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA853823A
Other languages
English (en)
Inventor
David Alexander Rawlins
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10561403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA853823(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA853823B publication Critical patent/ZA853823B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA853823A 1984-05-23 1985-05-21 Pharmaceutical composition ZA853823B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848413191A GB8413191D0 (en) 1984-05-23 1984-05-23 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA853823B true ZA853823B (en) 1986-04-30

Family

ID=10561403

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA853823A ZA853823B (en) 1984-05-23 1985-05-21 Pharmaceutical composition

Country Status (12)

Country Link
US (2) US4719228A (OSRAM)
EP (1) EP0163178B1 (OSRAM)
JP (1) JPH0772128B2 (OSRAM)
CA (1) CA1255222A (OSRAM)
DE (1) DE3580304D1 (OSRAM)
ES (1) ES8800039A1 (OSRAM)
GB (1) GB8413191D0 (OSRAM)
GR (1) GR851254B (OSRAM)
IE (1) IE57732B1 (OSRAM)
MX (1) MX163564B (OSRAM)
NZ (1) NZ212148A (OSRAM)
ZA (1) ZA853823B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248700A (en) * 1982-05-14 1993-09-28 Akzo Nv Active agent containing solid structures for prolonged release of active agents
JPS6245537A (ja) * 1985-08-23 1987-02-27 Sumitomo Electric Ind Ltd 医用樹脂組成物及びその製造方法
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
US5030446A (en) * 1990-01-24 1991-07-09 Revlon, Inc. Oil- and talc-free cosmetic powder composition
DK0448091T3 (da) * 1990-03-23 1999-05-03 Yoshitomi Pharmaceutical Farmaceutisk præparat indeholdende et i ringe grad vandopløseligt medikament
ES2088523T3 (es) * 1991-09-05 1996-08-16 Tsumura & Co Procedimiento de preparacion de capsulas de gelatina dura que contienen extractos de hierbas chinas.
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE19506141A1 (de) * 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
US5766668A (en) * 1995-03-27 1998-06-16 Chinook Group, Inc. Method for synthesizing chloride based feed precursor and product resulting therefrom
SE9704400D0 (sv) 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
DE19825687A1 (de) * 1998-06-09 1999-12-16 Degussa Wirkstoffkonzentrat
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
DE69927708T2 (de) * 1998-12-23 2006-07-06 Alza Corp., Mountain View Dosierungsformen, die poröse partikel enthalten
CA2474838C (en) 2002-02-01 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
EP1358805A1 (en) * 2002-04-30 2003-11-05 Aventis Animal Nutrition S.A. Animal feed supplement
EP1601347A1 (en) * 2003-02-19 2005-12-07 LifeCycle Pharma A/S Use of a silica or silica derivative as a sorption material
CA2516448A1 (en) * 2003-02-19 2004-09-02 H. Lundbeck A/S Method for preparation of an agglomerate using melt agglomeration
EP1653927B1 (en) 2003-08-04 2012-01-11 Bend Research, Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
EP1680086A2 (en) * 2003-10-10 2006-07-19 LifeCycle Pharma A/S A solid dosage form comprising a fibrate and a statin
US20050096390A1 (en) * 2003-10-10 2005-05-05 Per Holm Compositions comprising fenofibrate and pravastatin
JP5069001B2 (ja) * 2003-10-10 2012-11-07 ベロクシス ファーマシューティカルズ エー／エス フィブラートを含む固体投与形態
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
WO2005058281A1 (en) * 2003-12-17 2005-06-30 Schering Corporation Hydroxysteroid dehydrogenase inhibitors adsorbed on hydrophilic carriers
MX2007009915A (es) * 2005-02-15 2007-11-06 Elan Pharma Int Ltd Formulaciones en aerosol e inyectables de benzodiazepina nanoparticulada.
PL2487162T3 (pl) 2007-02-23 2017-03-31 Gilead Sciences, Inc. Modulatory farmakokinetycznych właściwości środków terapeutycznych
SI2296633T1 (sl) 2008-05-02 2015-11-30 Gilead Sciences, Inc. Uporaba trdnih nosilnih delcev za izboljšanje predelovalnih sposobnosti farmacevtskega sredstva
US8535392B2 (en) * 2008-11-25 2013-09-17 Milliken & Company Solid polymeric colorant compositions
WO2019145557A1 (en) * 2018-01-29 2019-08-01 Specialites Pet Food Litter for promoting pet's in-litter elimination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
EP0076075B1 (en) * 1981-09-25 1986-11-20 Beecham Group Plc Pharmaceutically active benzopyran compounds
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern

Also Published As

Publication number Publication date
DE3580304D1 (de) 1990-12-06
GR851254B (OSRAM) 1985-11-25
AU589561B2 (en) 1989-10-19
EP0163178A3 (en) 1987-01-14
US4719228A (en) 1988-01-12
AU4280085A (en) 1985-11-28
US4859709A (en) 1989-08-22
IE57732B1 (en) 1993-03-24
ES8800039A1 (es) 1987-11-01
JPS60258113A (ja) 1985-12-20
MX163564B (es) 1992-06-01
NZ212148A (en) 1989-01-06
EP0163178A2 (en) 1985-12-04
ES543401A0 (es) 1987-11-01
JPH0772128B2 (ja) 1995-08-02
IE851262L (en) 1985-11-23
EP0163178B1 (en) 1990-10-31
GB8413191D0 (en) 1984-06-27
CA1255222A (en) 1989-06-06

Similar Documents

Publication Publication Date Title
GB2153678B (en) Pharmaceutical composition
EP0173990A3 (en) External pharmaceutical composition
ZA853823B (en) Pharmaceutical composition
GB8426672D0 (en) Pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
GB8410290D0 (en) Pharmaceutical compositions
GB8410289D0 (en) Pharmaceutical compositions
GB2153677B (en) Pharmaceutical composition
GB8513641D0 (en) Pharmaceutical composition
GB8409961D0 (en) Pharmaceutical compositions
GB2153676B (en) Pharmaceutical composition
GB8518565D0 (en) Pharmaceutical composition
GB8429710D0 (en) Pharmaceutical composition
GB8424514D0 (en) Pharmaceutical composition
GB8412995D0 (en) Pharmaceutical composition
GB8421779D0 (en) Pharmaceutical composition
GB8424167D0 (en) Pharmaceutical composition
GB8424509D0 (en) Pharmaceutical composition
GB8421583D0 (en) Pharmaceutical composition
GB8424510D0 (en) Pharmaceutical composition
IE841175L (en) Pharmaceutical composition
GB8424511D0 (en) Pharmaceutical composition
GB8513640D0 (en) Pharmaceutical composition
GB8424512D0 (en) Pharmaceutical composition
GB8424513D0 (en) Pharmaceutical composition